<?xml version="1.0" encoding="UTF-8"?>
<ref id="R8">
 <label>8.</label>
 <mixed-citation publication-type="book">
  <comment>Zhang C, Wu Z, Li JW, et al. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. 
   <italic>Int J Antimicrob Agents</italic>. 2020 March 29. [Epub ahead of print].
  </comment>
 </mixed-citation>
</ref>
